Is there an anti-adenoviral drug on the horizon?
Acta Ophthalmologica, 08/09/2012
Romannwski E – These preclinical studies have led to industry sponsored clinical trials which have been initiated with several agents NVC–422 (NovaBay), Zirgan (0.15% Ganciclovir gel, Bausch + Lomb), and FST–100 (0.4% povidone–iodine/0.1% dexamethasone, Foresight Biotherapeutics). The first antiviral to treat adenovirus ocular infections will hopefully be available in the not too distant future.



